ArticlePDF Available

Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd blood group systems among ethnic Thai blood donors from the north‐east of Thailand

Authors:

Abstract

We here report the first study of antigen and phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd antigens in north‐east Thai blood donors. Blood transfusion services aim to ensure availability of adequate and safe blood to minimize the development of transfusion reactions. For pre‐transfusion testing, the most important blood group systems are ABO and RhD. The transfusion of ABO‐compatible otherwise unknown phenotype blood may result in alloimmunization, especially in multi‐transfused patients. Extended red blood cell (RBC) phenotyping and selection of blood negative for specific antigens reduce post‐transfusion complications and allow for effective blood transfusion regimens to be achieved. A total of 13,567 regular repeated, voluntary Thai blood donors were included for red‐cell antigen typing of Rh (D, C, E, c, e). Samples from 12,768, 9,389 and 13,059 donors were typed for Kidd, M and Mia antigens, respectively. Amongst Rh antigens, e was the most common (96.80%) followed by C (95.50%), c (34.40%) and E (32.20%) with CCDee (60.00%) being the most common phenotype. For Kidd phenotypes, Jk(a+b+) was the most common (46.73%) and Jk(a−b−) was rare (0.07%). For the M and Mia antigen, M(+) was most frequently found (94.96%) and Mia(+) was found in 17.97% of individuals. Knowledge of red‐cell antigen phenotype frequencies in a population is helpful for creating a phenotype database of blood donors which can provide antigen‐negative compatible blood to patients with multiple alloantibodies. Moreover, provision of antigen‐matched blood can prevent alloimmunization in multi‐transfused patients.
Int J Immunogenet. 2019;1–6. wileyonlinelibrary.com/journal/iji  
|
 1
© 2019 John Wiley & Sons Ltd
1 | INTRODUCTION
Blood group antigens are polymorphic antigens located on the
red‐cell membrane, able to induce an immune response in individ‐
uals potentially at risk during pregnancy [haemolytic disease of the
foetus and newborn (HDFN)] or following transfusion [haemolytic
transfusion reactions]. The probability of an individual developing an
alloimmune response depends on the incidence of the antigen in the
population (Giblett, 1961) (known to vary between different popula
tions and ethnic groups), on its immunogenicity and on the patient's
immune status (Daniels, 2009; Schonewille, Haak, & Zijl, 1999).
Currently, 36 blood group systems and more than 316 differ
ent blood group antigens have been defined by the International
Society of Blood Transfusion (ISBT) (http://www.isbtweb.org).
Received:23Octob er2018 
|
Revised:14January2 019 
|
Accepted:11Februar y2019
DOI:10.1111/iji.12420
ORIGINAL ARTICLE
Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd
blood group systems among ethnic Thai blood donors from the
north‐east of Thailand
Amornrat V. Romphruk1| Chalawan Butryojantho1| Bhakwarin Jirasakonpat1|
Ninnate Junta1| Supawadee Srichai1| Chintana Puapairoj1| Piyapong Simtong2
1Blood Trans fusion Center, Facult y of
Medicine, Khon K aen Universit y, Khon
Kaen, Thailand
2Department of Clinical Immunology and
TransfusionSciences,FacultyofAss ociated
Medical Sciences, Kho n Kaen Universit y,
Khon Kaen, Thailand
Correspondence
AmornratV.Romphru k,Facult yofMedicine,
Blood Trans fusion C enter, Khon K aen
University, Khon K aen, Thailand.
Email: aromphruk@gmail.com
Funding information
Faculty of Medicin e, Khon K aen University,
Thailand,Grant/AwardNumber:MM61301
Abstract
We here report the first study of antigen and phenotype frequencies of Rh (C, c, E, e),
M, Mia and Kidd antigens in north‐east Thai blood donors. Blood transfusion services
aim to ensure availability of adequate and safe blood to minimize the development of
transfusion reactions. For pre‐transfusion testing, the most important blood group
systemsareABOandRhD.ThetransfusionofABO‐compatibleotherwiseunknown
phenotype blood may result in alloimmunization, especially in multi‐transfused pa‐
tients. Extended red blood cell (RBC) phenotyping and selection of blood negative for
specific antigens reduce post‐transfusion complications and allow for effective blood
transfusionregimens to be achieved.Atotalof13,567regular repeated,voluntary
Thai blood donors were included for red‐cell antigen typing of Rh (D, C, E, c, e).
Samplesfrom12,768,9,389and13,059donorsweretypedforKidd,MandMia anti
gens,respectively.AmongstRhantigens,ewasthemostcommon(96.80%)followed
byC(95.50%),c(34.40%)andE(32.20%)withCCDee(60.00%)beingthemostcom
monphenotype.ForKiddphenotypes,Jk(a+b+)wasthemostcommon(46.73%)and
Jk (a−b−)was rare( 0.07%).Fo rt heMan dMia antigen, M(+)wasmostfrequentlyfound
(94.96%)a ndMia(+)wasfoundin17.97%ofindividuals.Knowledgeofred‐cellantigen
phenotype frequencies in a population is helpful for creating a phenotype database
of blood donors which can provide antigen‐negative compatible blood to patients
with multiple alloantibodies. Moreover, provision of antigen‐matched blood can pre‐
vent alloimmunization in multi‐transfused patients.
KEYWORDS
blood group systems, phenotype frequency, red‐cell antigens
2 
|
   ROMPHRUK et al.
ABO, Rh, Kell , Kidd, Du ffy, MNS, P, Lewis and Lu theran ar e the
major blo od group syste ms (Daniels, 20 09; Smar t & Armstrong ,
2008).Alloantibodies against Rh(E, c), MNS (Mia)and Kidd(Jka)
blood gro ups are the mo st commonl y report ed in Asian po pula
tions(Cheng,Lee,&Lin, 2012;Romphruk etal.,2018;Tianetal.,
2018). Moreover, these antibodies have frequently been identi
fied as a cause of haemolytic transfusion reac tions and HDFN in a
rangeofstudies(Chatziantoniouetal.,2017;Michalewska,Ejduk,
&Pniewska,2005).
Blood transfusion services aim to ensure availability of ade
quate and safe blood with regards to transfusion‐transmitted in
fections and compatibility testing to minimize the development
of any major transfusion reactions. For pre‐transfusion testing,
themost importantbloodgroup systemsareABO and RhD. The
transfusionofABO‐compatiblebloodwithunknownphenotypes
for clinically significant antigens may result in alloimmunization,
especially in multi‐transfused patients. Therefore, knowledge of
red‐cell antigen phenotype frequencies in regular voluntary blood
donors would help us to assess frequencies of these phenotypes
and enable us to establish a donor data bank of red blood cell
(RBC) antigens. Furthermore, it would be beneficial to provide an
tigen‐negative compatible blood without delay to alloimmunized
patients and to prevent alloimmunization in multi‐transfused
patients.
Thalassaemia and haemoglobinopathies are major pub
lic health problems in South‐East Asian countries. In Thailand,
the average frequency of α0‐thalassaemia in the population is
2.5%–10%,haemoglobin(Hb) Const ant Springand Hb Paksé are
1%–8%, α+thalass aemia is 15%–20%, β‐thalassaemia is 3%–9%,
and Hb E is 30%–50% especially in the north‐eastern part of
the country (Fucharoen et al., 2002). According to the Clinical
Practice Guidelines formanagement of thalassaemiasy ndromes
in Thailand, the RBC antigen match for Rh and Mia blood group
systems is minimally required for transfusion to prevent alloim
munization (Fucharoen, Tanphaichitr, Torcharus, Viprakasit, &
Mekaewkunchorn,2014).T hefrequenciesofRB CantigensinThai
populations have been reported only from Bangkok (Fongsarun,
Nuchprayoon, & Yod‐in, 2002). Here, we aim to report for the
first time the RBC antigens and phenotype frequencies of various
blood groups (Rh, M, Mia and Kidd) among ethnic Thai blood do
nors from north‐east Thailand.
2 | MATERIALS AND METHODS
2.1 | Studied populations
This study was conducted in the Blood Transfusion Center, Faculty
of Medicine, Khon Kaen University, Thailand. Our centre is in
north‐east Thailand and supplies blood components for patients in
Srinagarind Hospital, which is a tertiary‐care multi‐specialty teach
ing hospital. We retrospectively examined the red‐cell phenotyping
of13, 597regular voluntary Thai blooddonors from2013to 2017.
These dat a were available on a computerized system.
2.2 | RBC phenotypes
Red blood cell phenot ypes (C , E, c, e, M, Mia and Kidd) of donors
were determined using an antigen‐typing gel test (K‐med, Khon
Kaen, Thailand) as per the manufacturer's instructions. Briefly,
red cells wereprepared as2%cell suspension in normalsaline so
lution. A n aliquot (25μl) was added to each well and centrifuged.
Agglutinated cellsformedared lineonthesurfaceof gelinthe mi
crotube or dispersed throughout the gel, indicating the presence of
the corre sponding ant igen. A compac t button of ce lls on the bot
tom of the microtube indicated the absence of the corresponding
antigen.
2.3 | Statistical analysis
Red‐cell antigen and phenotype frequencies of the various blood
group systems were calculated by direct counting. The results were
expressed as percentages. Data were managed and analysed using
Excel 2013 (Microsoft Corporation, Seat tle, WA). All statistical
analysiswasper formedusingGraphPadPrismsoftware(GraphPad,
Inc., La Jolla, CA, USA). The distribution of antigens/phenotypes
between this study and studies of other regional populations was
comparedusingthechi‐squaretest.Ap‐value<0.05wasconsidered
statistically significant.
2.4 | Study approval
The present study was approved by the Khon Kaen University Ethics
Committeeforhumanresearch(HE611256).
3 | RESULTS
Intota l,13, 597r egula rdono rswerein cludedforred‐ cellanti gentyp
ingofRh(C,E, c, e).Ofthese, only12,768,9,389and13,059were
tested for Kidd, M and Miaantigens,respectively.AmongstRhan
tigens, e was the most common(96.80%) followedbyC (95.50%),c
(34.40%)andE(32.20%). The antigen frequencies of Rh (C, c,E,e),
Kidd, M an d Mia systems and comparisons with other regional popula
tions are summarized in Table 1. Table 1 also shows 9 Rh phenotypes,
with CCDeebeing the most commoninour population (60.00%), a
significantly higher frequency than Thais in Bangkok. The distribu
tion of Rh blood group phenotypes differed significantly between
this study and those of the other populations, except the Chinese
in Malaysia. For the Kidd blood group system, the frequencies of
Jka andJkbwere74.14%and72.52%,respectively.Jk(a+b+)wasthe
mostc ommonphen ot ype(46.73%)o bs er ve d.Ina dd it ion,9of12, 768
(0.07%)possessedtherareJk(a‐b‐)phenotypepreviouslyunreported
from Taiwan(Lin, Broadberry,& Chang,1988). TheM(+)phenoty pe
(94.96%)was ve ry commo n in our popul ation and at a sig nificant ly
hi g her fre q u enc y tha n Tha isi nBa n gko k(8 3 .60% ),C h ine s ei n Mal ays i a
(81.50%),Taiwanese(79.70%),MainlandChinese(77.20%)andnorth
Indians (90.55%). ThefrequencyoftheMia(+)antigenwasobserved
    
|
 3
ROMPHRUK e t al.
in17.97% of ou rs tud yp op ul ationan dsho we dasign if ica ntdiffere nc e
fromThaisinBangkok(9.10%)(p < 0.01).
4 | DISCUSSION
Frequency of RBC phenotypes varies among different populations
and ethnic groups, and is thus of interest in the fields of anthro
pology and forensic medicine, as well as in transfusion medicine.
RBC incompatibilities are responsible for alloimmunization and may
cause haemolytic transfusion reactions and HDFN, with different
degrees of s everity. In addition , haemoglobin E‐β0‐thalassaemia and
homozygous β0‐thalassaemia are the most common chronic trans
fusion‐dependent thalassaemias in Thailand. The prevalence of al
loimmunization in thalassaemia patients at our Blood Transfusion
Centerhasbeendetec tedtobe19.3%(Romphruketal.,2018).Th e
detection of RBC phenotypes either among patients who required
chronic transfusions or donors would be useful to reduce alloim
munizationand haemolytic transfusion reactions. Although there
has been studied on RBC phenot ype frequencies in ethnic Thai
populations (Fongsarun et al., 2002), there are no data from north‐
east Thailand. Our previous studies on other aspects of molecular
genetics,suchashumanleucocyteantigens(HL A),humanneutro
philantigens(HNA)andkillerimmunoglobulin‐likereceptors(KIRs),
revealed significant differences in frequency of alleles/molecules
in different regions of Thailand (Chaisri et al., 2013; Romphruk et
al., 2010; Simtong et al., 2018). Here, we report for the first time
the antigen and phenotype frequencies of blood group systems
(Rh, M, Mia and Kidd) by gel technology among ethnic Thai blood
donors in the north‐east of Thailand.
TABLE 1 Comparison of phenotypic distribution of Rh (C , c, E, e), Kidd, M and Mia antigensindifferentpopulations
Populations
(Number of
subjects)
Phenotype frequencies (%)
Thais (this study) Thais in Bangkoka
Chinese in
MalaysiabTaiwanesec,dMainland ChineseeNorth Indiansf,g
(9, 389−13 ,597 ) (985 −20 , 569) (200) (1,000−1,598) (1,412) (508−51,857)
Rh system
C95.50 8 3.7096 .00 91.6 088.008 7. 10
c34.40 48.30 34.50 51. 6 0 57. 5 0 51. 5 0
E32.20 38.6 023.0 043.50 50.4019. 70
e96.8 0 87. 4 0 97.50 93 .80 91.20 91.6 0
CCDee 60.00 4 9.4 061 .50 47. 8 0 41 .16 40 .95
CcDEe 22 .10 19.9 015 .00 *34.6038 .8714 .5 4
CcDee 7. 4 0 10.90 15.0 0*8.20 7. 5 9 30 .91
CCDEe 5.40 2.20 3.50 0.90 0.570. 32
ccDEE 2.50 11. 20 1.00 5 .907. 02 0.78
ccDEe 1.70 3.90 3.00 2.00 3.653.69
CcDEE 0.50 1.201.0 0 0.30 0.64 0.40
ccDee 0.30 1.10 00.30 0.36 1 .15
CCDEE 0.10 0.20 0 0 0.14 0
Kidd system
Jka74.14 76. 80 79. 0 0 72.00 67. 99 76.77
Jkb72.52 73.5 60.50 78.50 75. 57 78.89
Jk(a+ b−) 2 7.41 26.5 0 36.0 021. 5023 .9430 .71
Jk(a+b+) 46.73 50.3 043.00 50. 5044.05 46.06
Jk(a−b+) 25.79 23.20 17. 5 0 28.0 0 31. 5222.83
Jk(a−b−) 0.07 0.06 3.5000. 500.39 *
MNS system
M+ 94.96 83.60 81.5 079. 70 77. 2 0 9 0.55
Mia + 17.97 9. 10 no data 7.3NT no data no data
Note. “NT ”; no statistical testing b ecause no exact numbers of the subjects have been provided by the respec tive author.
Bold and italic = significant difference compared to this study.
aFongsarun et al., 2002, bMusa et al., 2012, cLin et al., 1988,dBroadberry et al., 1994, eYu et al., 2016, fMakroo et al., 2014, gAgarwal et al.,2013.
*p<0.05,p < 0.01.
4 
|
   ROMPHRUK et al.
The Rh blood group system is complex and contains many anti
gens that are highly immunogenic. These antigens are the second‐
most potent for triggering an immune reac tion, af ter those of the
ABObloodgroup.Anti‐Rhalloantibodiescancausesevereorfatal
haemolytic transfusion reaction and severe HDFN (Chatziantoniou
et al., 2017; Michalewska et al., 2005). Overall, the frequencies
of all antigens (C, c, E, e) in this study differed from those Thais
in Bangkok (Fongsarun et al., 2002), Mainland Chinese (Yu et al.,
2016), north In dians (Makroo, Gu pta, Bhatia, & Ros amma, 2014)
andTaiwane se(Lineta l.,1988).H owever,ourstu dypop ulati onh ad
frequencies of C, c and e similar to those of Chinese in Malaysia
(Musa et al., 2012). We confirmed that the e antigen is the most
frequentfollowedbythe Cantigen (87.40%–97.50%and83.70%–
96.00% , respectively)among Asian individuals.In our cohort, the
CCDee (R1R1) phenotype was the commonest (60.00%), as it is
in other A sian populat ions. Finall y,our s tudy repo rts the hi ghest
known fre quency of CCDEe phen otype (5.40%). The most com
mon alloantibodiesinThaipatientsareanti‐E (39.50%) and anti‐E
combinedwithanti‐c (25.30%), whichareproducedin transfused
R1R1 patients (Romphruk et al., 2018). Thus, these alloimmunized
patients should receive antigen‐negative blood (E antigen‐ and c
antigen‐negative). Fortunately, donors with the R1R1 phenotype are
very common in our region.
TheKidd bloodgroupiscomposed ofJka,JkbandJk3 antigens,
andfourphenotypes:Jk(a−b+),Jk(a+b+),Jk(a+b−)andJk(a−b−).These
antigens are associated with urea transporter UT‐B (Sands, 2003).
Thephenot ype Jk(a+b+) was the mostcommon (46.73%) and simi
lartothefrequenciesin ChineseinMalaysia(43.00%)(Musaetal.,
2012),MainlandChinese(44.05%)(Yuetal.,2016)andnorthIndian
populations (46.06%)(Agarwal, Thapliyal, & Chatterjee, 2013), but
significantlylowerthanThaisinBangkok(50.30%)(Fongsarunetal.,
2002)andTaiwanese(50.50%)(Linetal.,1988)(p < 0.01). The Kidd
antigenisimportant in transfusionmedicine.Anti‐Kidd antibodies
are well known for transient detectability and for their involvement
inhaemolytictransfusionreactions.Onceanti‐Jka is formed, the an‐
tibody frequently diminishes in strength so that standard antibody
screeningmethodsfailtodetect it(Kay,Poisson, Tuma,&Shulman,
2016). Thus, these antibodies are dangerous as a cause of clinically
signific ant delayed haemoly tic transfusion reaction (DHTRs) (Heddle
etal.,1995).TheJk(a‐b‐)phenotypewassignificantlylessfrequent
than in Chi nese in Malaysia (3 .50%) (Musa et al., 2012), Ma inland
Chinese(0.50%)(Yuetal.,2016)andnorthIndians(0.39%)(Agar wal
et al., 2013). Ind ividuals with t he Jk(a‐b‐) phenoty pe can develop
rareanti‐Jk3, which is likely to result in acute and delayed haemo‐
lytic transfusion reactions and difficulty in finding compatible blood
(Zhuang et al., 2013).
The M antigen belongs to the MNS blood group system and is
carriedbyglycophorinA.Phenotypingin9,389subjectsinthisstudy
revealed M(+)asthemostcommonphenotype(94.96%),afrequency
significantly higher than in many other populations (Table 1). This
implies that there are few susceptible M(−)individualswhoareatrisk
of producing anti‐M through incompatible transfusion or pregnancy.
In accordance with our previous work, anti‐M is of low frequency
intransfused patient s, representing 1.60%ofallcommon clinically
relevant antibody specificity (Romphruk et al., 2018). This contrasts
withthe10%frequencyofpositiveantibodyinpregnantCaucasian
women (De Young‐Owens, Kennedy, Rose, Boyle, & O'Shaughnessy,
1997). However, anti‐M can c ause severe haemolytic t ransfusion
reaction and HDFN ( Wikman, Edner, Gr yfelt, Jonss on, & Henter,
2007). In t he literatur e, anti‐M is identif ied freque ntly in patient s
who have never been immunized via transfusion or pregnancy (Klein
etal.,2014).
Mia antigen is previously described as the Miltenberger sub
system in MNS system, resulting from recombination of the GYPA
and GYPB genes (hybrid glycophorin). Surprisingly, the Mia(+) a n
tigen frequency in our study(17.97%) is significantlyhigher than
thatreportedinThaisinBangkok(9.10%).Anti‐Mia is the second‐
mostcommonlyfoundalloantibodyinAsiansbutisuncommonin
Caucasians. Recently, we found this alloantibody to be common
in north‐east Thailand (19.40%) (Romphruk et al., 2018). The
presence of anti‐Mia is associated with HL A ‐D RB1*0 9 (Chu et al.,
2009),anallelecommoninourpopulation(7.10%) (Romphruket
al., 2010). Following these observations, it would be interesting to
identif y any possible association between polymorphism of HLA‐
DR B1*09 and the occurrence of anti‐Mia alloantibody in the Thai
population.
At our Bloo d Transfusion Cente r,ant igen‐matched RB C pro
grammeforthalassaemiapatientshasbeen,since2008,65.6%of
all patients had received Rh (D, C, c, E, e) antigen‐matched and
19.2%receivedMia antigen‐matched RBCs. Based on the outcome
after implemented, a trend towards low alloimmunization rates
wasnotedintheantigen‐matchedRBCgroup,where3.5%ofpa
tients were alloimmunized (Romphruk et al., 2018). Moreover, a
phenotype database of blood donors also has been established at
our Blood Center which can provide the rare blood type such as
Jk(a−b−) and antigen‐negativecompatiblebloodto patientswith
multiple alloantibodies.
In conclusion, we have described the frequencies of dif ferent
blood group antigens and phenot ypes among ethnic Thai blood do
nors in the north‐east of Thailand. Our results indicate that the dis
tributions of RBC antigens differ in different ethnic groups, which
may be the result of different genetic and geographical origins. In
addition, knowledge of RBC antigen phenotype frequencies in a pop
ulation is helpful for creating a phenotype database of blood donors
for preparation of indigenous cell panels, and to help us to seek an
tigen‐negative compatible blood for patients with multiple alloanti
bodies and to prevent alloimmunization in multi‐transfused patients.
ACKNOWLEDGEMENTS
This work was supported by the Faculty of Medicine, Khon Kaen
University, Thailand (MM61301). We would like to thank the staf f
at Blood Transfusion Center, Faculty of Medicine, Khon Kaen
University, for the results of RBC phenotyping that was crucial for
thisstudy.Wewouldliketoacknowledge Prof.DavidBlairforedit
ingthemanuscriptviaPublicationClinicKKU,Thailand.
    
|
 5
ROMPHRUK e t al.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
AUTHOR CONTRIBUTION
A. V.R. designedthestudy,analysedtheexperiment,andcritically
discusse d and finalize d the manuscr ipt. C. B., B . J., N. J. and S. S .
contributedtotheacquisitionofdata.C.P.contributedtoreagent/
material.P.S.contributedtoanalysis,interpretedthedataandwrote
the manuscript.
ORCID
Piyapong Simtong https://orcid.org/0000‐0001‐5216‐8700
REFERENCES
Agar wal,N.,Thapliyal,R .M., &Chatterjee,K .(2013). Bloodgroupphe
notype frequencies in blood donors from a tertiary care hospital
in north India. Blood Research, 48, 51–54. https: //doi.org/10.5 045/
br. 2013 . 48 .1 . 51
Chaisri, S., Kitcharoen, K., Romphruk, A . V., Romphruk, A., Witt, C.
S., & Leelayuwat, C. (2013). Polymorphisms of killer immuno
globulin‐like receptors (KIRs) and HL A ligands in northeastern
Thais. Immunogenetics, 65, 645–653. https://doi.org/10.1007/
s00251‐013‐0716‐7
Chatziantoniou, V., Heeney, N., Maggs, T., Rozette, C., Fountain, C.,
Watts, T., … Rob inson, S. ( 2017). A descr iptive sing le‐centre e xpe
rience of the management and outcome of maternal alloantibod
ies in pregnancy. Transfusion Medicine, 27, 275–285. https://doi.
org /10.1111/tm e.1 243 0
Cheng,C.K.,Lee,C.K.,&Lin,C.K.(2012).Clinicallysignificantredblood
cellantibodiesinchronicallytransfusedpatients:AsurveyofChinese
thalassemia major patient s and literature review. Transfusion, 52,
2220–2224.https://doi.org/10.1111/j.1537‐2995.2012.03570.x
Chu, C. C., Ho, H. T., Lee, H. L., Chan, Y. S., Chang, F. J., Wang, C.
L., & …Lin, M., (20 09). Anti‐"Mi(a)" immunization is associated
with HL A‐DRB1*0901. Transfusion, 49, 472–478. https://doi.
org /10.1111/j.1537‐2995. 20 08 .01976.x
Daniels, G. (2009). The molecular genetics of blood group polymor‐
phism. Human Genetics, 126, 729–742. https://doi.org/10.1007/
s00 439‐ 00 9‐0738‐2
De Young‐Owens, A., Kennedy, M., Rose, R. L., Boyle, J., &
O'Sha ughnessy, R. (1997). Ant i‐M isoimmuni zation: Manage ment
and outcome at the Ohio State University from 1969 to 1995.
Obstetrics & Gynecology, 90, 962–966. https://doi.org/10.1016/
S0029‐7844(97)00476‐6
Fongsarun,J.,Nuchprayoon,I.,& Yod‐in,S.(2002).BloodgroupinThai
blood donors. Journal of Hematology and Transfusion Medicine, 12,
277–286.https://doi.org/10.7754/clin.lab.2013.130806
Fucharoen, G., Fucharoen, S., Sanchaisuriya, K., Sae‐ung, N.,
Suyasunanond,U.,…Chinorak,P.(2002).Frequencydistributionand
haplotypic heterogeneity of βE‐globin gene among eight minority
groups of northeast Thailand. Human Heredity, 53, 18–22. https://
doi.org/10.1159/000048600
Fucharoen, S., Tanphaichitr, V. S., Torcharus, K., Viprakasit, V., &
Mekaewkunchorn,A .(2014).Clinical practice guidelines for diagnosis
and management of thalassemia syndromes (in Thai), 1st ed. Bangkok,
Thailand:P.A.Living.
Giblet t, E. R. (1961). A critique of the theoretical hazard of inter vs .
intra‐racial transfusion. Transfusion, 1, 233–238. https://doi.
org /10.1111/j.1537‐2995.1961 .tb 0 00 48 .x
Heddle,N. M.,Soutar,R.L.,O'Hoski,P.L.,Singer,J.,McBride,J.A., Ali,
M.A., …Kelton, J. G. (1995).A prospectives tudy to determine the
frequency and clinical significance of alloimmunization post‐trans
fusion. British Journal of Haematology, 91, 1000–1005. https://doi.
org/10.1111/j.1365‐2141.1995.tb05425.x
Kay,B.,Poisson,J.L.,Tuma,C.W.,&Shulman,I.A.(2016).Anti‐Jkathat
are detec ted by solid‐phase red blood cell adherence but missed by
gel testing can cause hemolytic transfusion reactions. Transfusion,
56,2973–2979.https://doi.org /10.1111/trf.13782
Lin,C .M.,Broadb err y,R.E.,&Chang,F.J.(1988).Thedistributionofbloo d
group antigens and alloantibodies among Chinese in Taiwan. Transfusion, 4,
350–352.http s://doi.org/10.104 6/j.1537‐2995.198 8. 284 88265265.x
Makroo , R., Gupta, R ., Bhatia, A. , & Rosamma, N. L . (2014). Rh phe
notype, allele and haplotype frequencies among 51,857 blood
donors in North India. Blood Transfusion, 12, 36–39. https://doi.
org/10.2450/2013.0300‐12
Michalewska, B., Ejduk, A ., & Pniewska, K. (2005). Acute hae
molytic transfusion reaction apparently caused by the
'enzyme‐only' anti‐E. Vox Sanguinis, 89, 61. https://doi.
org /10.1111/j.1423‐ 0 410. 20 05. 00641.x
Musa, R . H., Ahmed, S. A ., Hashim, H., Ayob, Y., Asidin, N. H.,
Choo, P. Y., … Al‐Joudi, F. S. (2012). Red cell phenotyping of
blood from donors at the National blood center of Malaysia.
Asian Journal of Transfusion Science, 6, 3–9. https://doi.
org /10.4103/0973‐ 6247.95042
Romphruk, A. V., Romphruk, A., Kongmaroeng, C., Klumkrathok, K.,
Paupairoj,C.,&Leelayuwat,C.(2010).HLAclassIandIIallelesand
haplot ypes in ethnic Nor theast Thais. Tissue Antigens, 75, 7 0 1–7 11 .
https://doi.org/10.1111/j.1399‐0039.2010.01448.x
Romphr uk, A. V., Simtong , P. , Butryojan tho, C., Pimp humee, R., J unta,
N.,Srichai,S.,Puapairoj,C.(2018).Theprevalence,alloimmunization
risk fac tors, antigenic exposure, and evaluation of antigen‐matched
red bloo d cells for thal assemia tran sfusions: A 10‐ye ar experie nce
at a tertiary care hospit al. Transfusion, 59(1), 177–184. https ://doi.
org /10.1111/tr f.15002
Sands, J. M. (2003). Molecular mechanisms of urea transport . The
Journal of Membrane Biology, 191, 149–163. ht tps://doi. org/10.10 07/
s00232‐002‐1053‐1
Schonewille, H.,Haak, H.L., & van Zijl, A.M. (1999).Alloimmunization
after blood transfusion in patients with hematologic and on
cologic diseases. Transfusion, 39, 763–771. https://doi.
org/10.1046/j.1537‐2995.1999.39070763.x
Simtong,P.,Romphruk,A.V.,Hofmann,C.,Reil,A.,Sachs,U.J.,&Santoso,
S.(2018).AssessmentofHNAalloimmunisationriskinNortheastern
Thais, Burmese and Karen . Transfusion Medicine, 28,47–55.https://
doi .or g/10.1111/tme .124 31
Smart, E., & Armstrong, B. (20 08). Blood group sys
tems. ISBT Science Series, 3, 68–92. https://doi.
org /10.1111/j.1751‐2824. 20 08 .0 018 8. x
Tian, L ., Hou, L ., Wang, L ., Xu, H., X iao, J., & Ying, B. (2018). HLA‐
DRB1*09:01 allele is associated with anti‐E immunization in a Chinese
population. Transfusion, 58, 15 36–1539. ht tps://doi .or g/10 .1111/
trf.14568
6 
|
   ROMPHRUK et al.
Wikman , A., Edner, A., Gr yfelt, G., Jonsson, B ., & Henter, J. I.
(2007). Fetal hemolytic anemia and intrauterine death caused
by anti‐M immunization. Transfusion, 47, 911–917. https://doi.
org /10.1111/j.1537‐2995. 20 07.01209.x
Yu,Y.,Ma, C., Sun,X.,G uan, X., Zhang,X., Saldanha, J., …Wang, D.(2016).
Frequen cies of red blood ce ll major blood g roup antigens an d phenotyp es
in the Chinese Han population from Mai nland China. International Journal
of Immunogenetics, 43,226–235.https://doi.org/10.1111/iji.12277
Zhuang,G.Y.,Liu,S.F.,Zuo,F.,Zhang,Z.,Zhang,L.,Yu,Y.,…Miao,T.H.
(2013). Arare caseofJk(a‐b‐)to produce anti‐Jk3andtransfusion
strategy. Chinese Journal of Blood Transfusion, 8,760.(InChinese).
How to cite this article:RomphrukAV,ButryojanthoC,
JirasakonpatB,etal.PhenotypefrequenciesofRh(C,c,E,e),
M, Mia and Kidd blood group systems among ethnic Thai
blood donors from the north‐east of Thailand. Int J
Immunogenet. 2019;00:1–6. https: //doi.org/10.1111/iji.1242 0
... The distribution of these glycophorins varies between ethnic populations. The Mi a antigen is quite different when comparing Thai populations-central Thais (9.7%) [6], southern Thais (4.7%) [7], and northeastern Thais (17.9%) [8]. ...
... Avoiding alloimmunization for other Rh blood group antigens (D, C, c, E, or e) is routinely performed in European systems for women and patients receiving a chronic transfusion, patients with thalassemia, and sickle cell anemia [9]. In Thailand, the Clinical Practice Guidelines for the management of thalassemia syndromes define the minimal requirement for red blood cell (RBC) antigen matching, including Rh and MNS blood group systems for transfusion to prevent alloimmunization [8]. ...
... However, antibodies to non-ABO antigens (alloantibodies) often develop in multi-transfused patients exposed to RBC antigens different from their own. Phenotyping Rh (C, c, E, and e) and Mi a is required for matching donors and recipients to reduce post-transfusion reactions [8,[19][20][21]. Technically, serological blood typing still requires a longer turnaround time and is more expensive (column agglutination method). ...
Article
Full-text available
The MNS7 (Mia) blood group antigen is found at a different prevalence among different ethnic groups. Anti-Mia can cause hemolytic disease of the fetus and newborn (HDFN) and both acute- and delayed-type hemolytic transfusion reactions (HTR). Mia typing should be performed in donors to prevent life-threatening hemolytic transfusion reactions. The gel card and standard tube methods still need specialized equipment, centrifugation, and expertise for result interpretation. We used a novel paper-based analytical device (PAD) pre-coated with monoclonal IgM anti-Mia for Mia phenotyping. We measured grey pixel intensity in blood typing results for interpretation processing using OpenCV at the sample (SP) and elution parts (EP); furthermore, we used the SP: EP ratio and F-score as analysis criteria. We typed 214 blood EDTA samples with PAD–Mia and then compared with gel card results for setting an analysis criterion. We observed 100% sensitivity, specificity, and accuracy when we applied the SP: EP ratio and F-score with the optimal criterion (1.07 and 0.17 for SP: EP ratio and F-score, respectively). The validation of PAD–Mia typing for blood donor samples (n = 150) via F-score gave 100% sensitivity and specificity when compared with the gel card method; therefore, we argue that PAD–Mia typing can be used for Mia phenotyping without sero-centrifugation. Moreover, to study the correlation between genotype and phenotype, PCR-SSP was performed to identify GYP(B-A-B) hybrids. The results revealed that all Mia+ blood samples gave a positive with GP. Hut, GP. HF, GP. Mur, GP. Hop, and GP. Bun. Results of the gel card method and PCR-SSP were concordant. Hence, using PAD–Mia typing in blood donors would be helpful for creating a phenotype database of blood donors for reducing alloimmunization risks.
... The majority of the patients had severe forms of thalassemia, including 738 patients with Hb E/betathalassemia (73.8%) and 113 patients with beta-thalassemia major (11.3%). The mean age in this cohort was 23 ...
... 11,16,22 Moreover, a study of antigen frequencies of Rh (C, c, E, e) and MNS (M, Mi a ) blood group systems among Thai blood donors showed low frequencies of E (32.2%), c (34.4%), and Mi a (17.9%) antigen. 23 These data support the high incidence of alloimmunization against E antigen (28.2%), c antigen (11.3%), and Mi a antigen (15.8%) in this cohort, which may be explained by the mismatch between donor and recipient antigen. In Thailand, the national blood bank policy and the practice guideline by the Thai Society of Hematology recommend extended RBC matching, including the Rh system (C, c, E, e) and Mi a in multitransfused patients. ...
Article
Background: Thalassemia is a common genetic disease in Southeast Asia. Red blood cell (RBC) transfusion is an essential treatment for severe forms of thalassemia. We performed a study to demonstrate RBC alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia (TDT). Study design and methods: A multi-center web-based registry of TDT was conducted in eight medical centers across Thailand. Thalassemia information, transfusion therapy, and transfusion-related complications were collected. Factors associated with each complication were demonstrated using the logistic regression analysis. Results: Of 1000 patients recruited for the study, 449 were males (44.9%). The mean age was 23.9 ± 15.4 years. The majority of patients, 738 (73.8%) had hemoglobin E/beta-thalassemia. In the study, 421 transfusion-related complications were reported from 357 patients (35.7%). Alloimmunization was the most common complication which was found in 156 patients (15.6%) with 284 positive antibody tests. The most frequent antibodies against RBC were anti-E (80/284, 28.2%) followed by anti-Mia (45/284, 15.8%) and anti-c (32/284, 11.3%). Age ≥3 years at initial blood transfusion, splenomegaly, higher frequencies, and volumes of transfusion were significant factors associated with alloimmunization. None of the patients had to terminate blood transfusion due to multiple alloantibodies. Other commonly seen complications were allergic reactions (130, 13.0%), autoimmune hemolytic anemia (70, 7.0%) and febrile non-hemolytic transfusion reaction (54, 5.4%). Conclusions: Transfusion-related complications, especially alloimmunization, were common among Thai patients with TDT. Extended RBC antigen-matching for the Rh system and Mia should be implemented to prevent the development of alloantibodies in multi-transfused patients.
... [10] In the Thailand study of Romphruk et al., it was reported that negativity was observed in e 3.2%, C 4.5%, c 65.6%, and E 67.8%. [11] In the study of Shah et al., among the Rh subgroup antigens, negativity C 9%, c 49.5%, E 83.5%, and e 0.5% were reported. [12] As can be seen, the negativity of c and E antigens is more common in the literature. ...
Article
Full-text available
Objective: It was aimed to profile the blood subgroups of our region and to reveal the prevalence of auto/alloimmune sensitization in patients who had to undergo multiple erythrocyte transfusions and to establish the sensitization profile by screening major and minor subgroups. Materials and Methods: In this study, the distribution of ABO and Rh system major subgroups was studied in 100 donor blood. As the patient group, 50 patients who received three or more red blood cell transfusions were included. In addition to this group, Kell, Lewis, Duffy blood group systems were studied. Results: According to the ABO system, 35% of the donors were in O, 33% in A, 17% in AB, and 15% in B. According to the Rh system, 75% is Dvi positive. Rh system is 99% e positive and 33% E positive in major subgroups and Kell1 positivity is 8%. In the patient group, 22% D(‑) was determined compared to Rh blood group. Among the major subgroups of Rh, C was 68%, E was 14%, c was 76%, and e positivity was found to be 100%. The Kell1 negativity rate is 96%. The highest negativity was found in 86% Lea antigen in Lewis system, in 36% S antigen in MNS system, 34% Fyb antigen in Duffy system, and 24% Jka antigen in Kidd system. When inappropriate blood is given for any antigen, a double population is formed. The double negativities we detected in our study occurred as follows according to blood group systems: E 18%, C 12%, c 8%, Cw 2%, Kell 1 2%, M 8%, N 4%, S 18%, s 6%, Fya 8%, Jka 6%, Jkb 22%. Indirect Agglutination Test (IAT) was negative in all patients. Conclusion: IAT negativity in all patient groups suggests that we do not develop alloimmunization, but the high rates of double population suggest a high risk of alloimmunization.
Article
Introduction: Erythrocyte alloimmunization may arise from blood group incompatibility between ethnically diverse donors and recipients. Providing blood to patients with rare or complex red cell antigen profiles poses a significant challenge. These individuals may have red blood cells that either lack high incidence antigens or possess a combination of several uncommon antigens. As a result, finding compatible blood donors becomes difficult. Methods: The objective was to identify extended phenotyping strategies for the various blood group systems to aid transfusion in patients with a phenotype considered rare. This is a systematic review, in which parameters were followed as a basis for the PRISMA recommendations with a focus on the search for the literature published in the last 10 years on erythrocyte phenotyping in blood donors, aiming to identify rare phenotypes for transfusion support. Results: We found 20 articles describing rare antigens and antibodies, reporting difficulties in finding compatible blood and the need for a registry of these blood donors. In summary, the provision of blood to patients with red cells lacking high incidence antigens or complex antigen profiles is indeed a challenging task. It necessitates specialized testing, access to rare blood donors, and alternative strategies to ensure the best possible match for transfusion.
Article
Full-text available
Background and objective: The antigen 'e' is one of the alloantigen, which can develop alloantibodies in multitransfused patients. Our study objective is to assess the antigen 'e' in the 'O' Blood group donors.
Article
The transfusion of ABO-compatible blood with blood with an unknown phenotype may result in alloimmunization, particularly in multitransfused patients. Minor blood-group phenotyping and the selection of negative blood for specific antigens reduce post-transfusion complications. With this study, a device called the DROP and READ instrument was developed with a PAD (paper-based device) and various software to phenotype ABO, Rh (D, C, c, E, e), and Mia antigens. EDTA (Ethylene diamine tetra-acetic acid) blood samples were collected from donors, volunteers, and newborns, and were then tested with the DROP and READ instrument according to the lateral flow and RBC agglutination principle. The results were compared with those obtained by using a routine column agglutination test or the tube method. Results: a total of 205 samples were tested (150 from EDTA blood donors, 50 from EDTA blood volunteers, and 5 from the cord blood of newborns). The device yielded 100% accuracy, sensitivity, and specificity, a positive predictive value, and a negative predictive value when interpreting the ABO, Rh (D, C, c, E, e), and Mia antigens. The DROP and READ instrument is developed to automatically interpret the results, and the device provided endpoint results without centrifugation and prevented misinterpretations from human error.
Article
Testing ABO and D (Rh) are priorities before blood transfusion, and the minor blood group antigen should be matched to reduce alloimmunization. In a recent study, a paper-based device (PAD) was developed for C, E, c, e, Mia phenotyping, combined with image-based high-throughput detection. A total of 148 ethylenediamine tetra acetic acid (EDTA) blood samples were used to evaluate and create an optimal criterion using OpenCV for high-throughput interpretation. Results revealed that anti-C, -c, -E, -e, and -Mia were successful for blood group phenotyping with area under the receiver operating characteristics curve (AUC) of 1.000 (95% confidence interval [CI], 0.976–1.000), 0.984 (95% CI, 0.984–0.997), 0.997 (95% CI, 0.970–1.000), 0.994 (95% CI, 0.965–1.000), and 1.000 (95% CI, 0.976–1.000), respectively. The validation of these systems for blind blood samples (n = 56) showed 100% sensitivity, specificity, and accuracy compared with the gel card method. PAD with image-based interpretation can be used as an alternative to minor blood group phenotyping without the need for electric power equipment and well-trained personnel. Moreover, this proposed method would help build phenotype databases of blood donors or patients for the preparation of panel cells, find antigen‐negative compatible blood for patients with multiple alloantibodies, and prevent alloimmunization in multitransfused patients.
Article
Full-text available
There are numerous scientific data about the study of the prevalence of blood group antigens in the different donor population. Several studies showed that the profile of major blood group antigens is not similar in blood donors from different local areas. Research objective: Our scientific goal was to study of the prevalence blood group antigens in the Georgian blood donor population. In the current study, we analyzed the 48 phenotypically combinations based on four major (ABO, Rh, Kell, and MN) blood groups. Research methods: The blood of 1009 donors has been studied on RBC antigens. The sample were collected from the diagnostic laboratory of Medina Ltd Health Centre of Batumi. Blood typing of the sample has been carried out on the basis of the immunogenetics laboratory of Batumi Shota Rustaveli State University. The universal monoclone antibodies was used for identify minor blood group antigens. We used as forward as reverse grouping methods. For identification erythrocytes, blood group antigens also were used ID cards, such as ABO/D + Reverse Grouping. Result: 12 phenotypic combinations have been identified in each O, A, B, AB group of ABO system. Out of 48 theoretically possible phenotypic combinations, we can actually find 1,9 times less phenotypes and the real amount is 25 phenotypes. The remaining 23 phenotypic combinations have not been observed in the studied donors. These are: 1. O, Rh-K+ MM; 2. O, Rh-K- MN; 3. O, Rh-K- NN; 4. A, Rh-K+ MN; 5. A, Rh-K+ MM; 6. A, Rh-K+ NN; 7. A, Rh-K- MM; 8. A, Rh-K- NN; 9. B, Rh+K+ NN; 10. B, Rh-K+ MN; 11. B, Rh-K+ MM; 12. B, Rh-K+ NN; 13. B, Rh-K- MN; 14. B, Rh-K- MM; 15. B, Rh-K- NN; 16. AB, Rh+K+ MN; 17. AB, Rh+K+ NN; 18. AB, Rh+K- NN; 19. AB, Rh+K- MM; 20. AB, Rh-K+ MN; 21. AB, Rh-K+ MM; 22. AB, Rh-K+ NN; 23. B, Rh-K- NN. The value of χ2 in the case is equal to 3221,16. The P-Value is < .00001. The result is significant at P < .05. Out of 1009 studied donors 349 are carriers of phenotypic group A (II), while 19 donors carry AB (IV) group specification. This means that 36.23% of the studied donors have A antigen on the surface of erythrocyte membrane. The majority of them A1 subgroup. Conclusion: As our research showed there is a quit high polymorphism of blood group phenotype combinations in Georgian blood donors in the example of one clinic. This kind of data is very important for the clinics' rational preparation of whole blood or blood components.
Article
Full-text available
Objectives: This study aimed to determine human neutrophil antigen (HNA) frequency, estimate possible HNA incompatibilities and predict the risk of HNA alloimmunisation in the Northeastern Thai, Burmese and Karen populations. Background: Alloantibodies against HNA are implicated in a number of clinical conditions, including immune-mediated neutropenia and transfusion reactions. Methods: A total of 400 unrelated healthy Thais, 261 Burmese and 249 Karen was included in this study. DNA samples were typed for HNA-1, -3, -4 and -5 systems using polymerase chain reactions with sequence-specific primers (PCR-SSP). Results: In this cohort, HNA-1a was more prevalent than HNA-1b. Accordingly, the possible risk of HNA-1a alloimmunisation against HNA-1a is lower than HNA-1b (0·0802-0·1351 vs 0·2293-0·2497). This is in contrast to the situation reported in Caucasian and African populations. The predicted risk of HNA-3 incompatibility in Thais, Burmese and Karen were 28·09%, 30·66% and 22·77%, respectively. The possible risks of HNA-3a alloimmunisation were 0·0493 in Thais, 0·0608 in Burmese and 0·0196 in Karen, respectively. No individuals were found to be homozygous for HNA-4bb. The probability of developing alloantibodies against HNA-4a was low in these populations and every population in Asia. In contrast, the overall frequency of HNA-5bb homozygous individuals was high in this study, peaking at 0·192. Conclusions: This is the first study that reported the allele frequencies of HNA-1, -3, -4, and -5 in a large sample of healthy unrelated individuals from ethnic Thais, Burmese and Karen. Our results indicated the high possible risk of HNA-1, -3 and -5 alloimmunisation in these populations.
Article
Full-text available
Killer cell immunoglobulin-like receptors (KIRs) are cell surface receptors on natural killer (NK) cells and subsets of T cells. The functions of NK cells are partly regulated by interactions between KIRs and HLA ligands on target cells. In this study, the presence or absence of 17 KIR genes and their known HLA ligands have been investigated in 235 unrelated individuals living in northeastern Thailand (NET). Subtypes of KIR2DS4 including full length (KIR2DS4F) and deleted forms (KIR2DS4D) have also been determined. Framework genes (KIR2DL4, 3DL2, 3DL3, and 3DP1) were found in all individuals and KIR genes belonging to the A haplotype (KIR2DL1, 2DL3, 3DL1, and 2DS4) were present in more than 90 % of NET. KIR2DS4D (61.7 %) was more common than KIR2DS4F (52.8 %). A total of 33 different KIR genotypes were observed. Of these, three new genotypes were identified. The most common genotype (AA) was observed in 35.7 % of NET, and HLA-C alleles bearing the C1 epitope (HLA-C1) had the highest frequency (97 %). All individuals had at least one inhibitory KIR and its corresponding HLA ligand; 40.9 % of NET had three pairs of receptor-ligand combinations, and 18.3 % had all three receptor-ligand combinations of KIR2DL3+C1, 3DL1+Bw4, and 3DL2+A11. Surprisingly, the patterns of KIR gene frequencies in NET are more similar to those of Caucasians than Japanese, Korean, and Chinese. This is the first report on complete analysis of KIR and known HLA ligands in Thais. These data provide basic knowledge on KIR for further studies on disease associations and transplantation in northeastern Thais.
Article
Full-text available
Knowledge about the frequency of red blood cell-antigen phenotypes in a population can be helpful in the creation of a donor data bank for the preparation of indigenous cell panels and for providing antigen-negative compatible blood to patients with multiple alloantibodies. ABO and RhD blood grouping was performed on 9,280 continuous voluntary and replacement donors. For other rare blood groups, 508 ACD blood samples were obtained from the donors at the Blood Bank of the Department of Transfusion Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Blood group antigens were determined by tube method using anti-sera (Bio-Rad, USA), and the phenotype frequencies were expressed as percentages. Group B (37.39%) was the most common, followed by group O (31.85%). R1R1 and rr were the most common phenotypes amongst Rh positive and Rh negative groups, respectively. A rare phenotype R2Rz was found in one donor. For Kidd and Duffy blood group systems, Jk (a+b+) and Fy (a+b+) were the most common phenotypes (46.06% and 48.03%, respectively). The most common phenotypes for MNSs, Lu, and Kell blood groups were M+N+, S-s+, Lu (a-b+), and K-k+, respectively. A very rare case of Fy (a-b-) and Jk (a-b-) was found in a single donor. This study is the first small step to create a rare donor data bank and to prepare indigenous cell panels to provide compatible blood to all multi-transfused alloimmunized patients.
Article
Background: Anti-E is the most common and important RBC alloantibody in the Chinese population. Several studies have demonstrated that the production of specific RBC alloantibodies is associated with HLA-DRB1 polymorphisms. Considering that the Chinese population has its own unique characteristics of HLA-DRB1 polymorphisms, we investigate whether specific HLA-DRB1 alleles are associated with E immunization in a Chinese population. Study design and methods: The frequencies of HLA-DRB1 phenotypes were compared among 78 patients possessing anti-E and 192 healthy blood donors. HLA-DRB1 genotyping was carried out using sequence-based typing method. The TEPITOPEpan software was used to predict E antigen-derived anchor peptides binding to HLA-DRB1 molecules. Results: The frequency of HLA-DRB1*09:01 phenotype was significantly higher in the patients with anti-E than in healthy controls: 76.9% versus 27.6% (odds ratio, 8.7; 95% confidence interval, 4.7-16.2; corrected p value < 0.0034). One E antigen-derived anchor peptide (217WMFWPSVNS225) was predicted to bind three HLA-DRB1 molecules (HLA-DRB1*04:05, *04:17, and *13:02); however, no anchor peptide was predicted to bind HLA-DRB1*09:01. Conclusion: This study indicated that HLA-DRB1*09:01 phenotype was significantly more prevalent in E-immunized patients than the control group. It suggested that HLA-DRB1*09:01 molecule might represent a susceptibility phenotype enhancing formation of anti-E alloantibody. Further study would be necessary to identify the anchor peptide responsible for E alloimmunization by stimulation of specific T cells by peptide originating from E antigen.
Article
Background: Haemolytic disease of the fetus and newborn (HDFN) occurs when maternal IgG alloantibodies to fetal red blood cell antigens cross the placenta, causing haemolysis in the fetus and/or neonate. After delivery, the main concern is hyperbilirubinaemia, which can cause neurological damage. Objectives: To summarise our current management and outcome data to inform health-care professionals counselling women whose pregnancies are at risk of HDFN and to compare these data with relevant studies. Methods: This is a retrospective descriptive study of all high-risk pregnancies at risk of HDFN at Guy's and St. Thomas' NHS Foundation Trust (GSTFT) Maternity Unit over a 7-year period. We defined high-risk pregnancies as those in whom anti-D, anti-c, anti-K or high (>32 or doubling strength) titres of all other antibodies were identified. Results: A total of 130 pregnancies in 112 women were followed up. A single alloantibody was found in 93 pregnancies (71.5%) and multiple alloantibodies in 37 pregnancies (28.5%). Anti-D was most commonly encountered (n = 48, 36.9%), followed by anti-c (n = 31, 23.8%) and anti-E (n = 15, 11.5%). In 65 of 130 pregnancies (50%), antibody concentrations triggered scans to screen for fetal anaemia. Of 130 pregnancies, 6 (4.6%) required intrauterine transfusions, and 31 of 130 (26%) neonates required post-natal intervention. Overall, morbidity was 0.1% and mortality 0.002%. Conclusions: This study demonstrates that morbidity and mortality caused by HDFN is minimal. These results are reassuring for women at risk of HDFN as even severely affected cases are successfully managed in most instances. Further studies are needed to identify predictors of disease severity.
Article
Background: Kidd blood group antibodies are notorious for transient detection and hemolytic transfusion reactions. This report compares the rate of detection of anti-Jk(a) when using gel column agglutination versus solid-phase red blood cell adherence (SPRCA) testing and documents the occurrence of hemolytic transfusion reactions in 17 recently transfused patients who developed anti-Jk(a) that were detectable by SPRCA but were undetectable by gel. Study design and methods: Before April 20, 2011, the laboratory used gel column agglutination as the primary method for antibody screening and identification. From April 20, 2011, to August 12, 2013, SPRCA was adopted as the primary method for antibody screen with gel remaining the primary method for identification. SPRCA identification was also performed if sufficient sample was available. Medical records were reviewed for evidence of hemolytic reaction in patients whose anti-Jk(a) was negative or inconclusive by gel, but clearly identifiable by SPRCA at the time the anti-Jk(a) was first identified. Results: A total of 105 patients were discovered with anti-Jk(a) from 88,478 SPRCA screens performed. In 32 patients, anti-Jk(a) was initially discovered by SPRCA testing and concurrent gel testing was completely negative (n = 26) or inconclusive (n = 6). Seventeen of the 32 patients were recently transfused and of these six met criteria for delayed hemolytic transfusion reaction (DHTR), three had possible DHTRs, and eight had delayed serologic reactions; 13 of the transfused patients received Jk(a-) RBCs to avoid potential hemolysis. Conclusion: SPRCA testing significantly increased the discovery of clinically significant anti-Jk(a) and facilitated the earlier use of Jk(a-) RBCs to avoid hemolytic transfusion reactions.
Article
Alloantibodies directed to red blood cell (RBC) antigens play an important role in alloimmune-mediated haemolytic transfusion reactions and haemolytic disease of the foetus and newborn. The frequencies and phenotypes of RBC antigens are different in populations from different geographic areas and races. However, the data on major blood group antigens in the Chinese Han population from Mainland China are still very limited; thus, we aimed to investigate them in this study. A total of 1412 unrelated voluntary Chinese Han blood donors were randomly recruited. All donors were typed for blood group antigens: D, C, c, E, e, C(w) , Jk(a) , Jk(b) ,M, N, S, s, Le(a) , Le(b) , K, k. Kp(a) , Kp(b) , Fy(a) , Fy(b) , Lu(a) , Lu(b) , P1 and Di(a) using serological technology. Calculations of antigen and phenotype frequencies were expressed as percentages and for allele frequencies under the standard assumption of Hardy-Weinberg equilibrium. Amongst the Rh antigens, D was the most common (98.94%) followed by e (92.28%), C (88.81%), c (58.43%), E (50.78%) and C(w) (0.07%) with DCe/DCe (R1 R1 , 40.72%) being the most common phenotype. In the Kell blood group system, k was present in 100% of the donors and a rare phenotype, Kp (a+b+), was found in 0.28% of the donors. For the Kidd and Duffy blood group systems, Jk (a+b+) and Fy (a+b-) were the most common phenotypes (44.05% and 84.35%, respectively). In the MNS blood group system, M+N+S-s+ (45.54%) was the most common, whereas M+N-S-s- and M-N+S-s- were not found. The rare Lu (a-b-) and Lu (a+b+) phenotypes were identified in 0.43% and 1.13% of the donors, respectively. Le(a) and Le(b) were seen in 17.92% and 63.03% of donors, respectively. The frequency of Di(a) was 4.75%, which was higher than in the Chinese population in Taiwan region or the Caucasian and Black populations (P < 0.0001). This study systematically describes the frequencies of 24 blood group antigens in the Chinese Han population from Mainland China. The data can be helpful in creating a donor database for preparation of indigenous cell panels and providing antigen-negative blood to patients with multiple alloantibodies.
Article
This study was performed to provide information on the frequencies of Rh antigens, alleles, phenotypes, and haplotypes from our region in India and to compare them with those from other races. This observational study was conducted on blood donors from March 2009 to August 2011 using a fully automated system for Rh typing of blood cells. The data were collected and calculations done to determine the antigen, phenotypes, allele and haplotype frequencies. The chi square test was used for comparisons between the results of our study and those of other studies. A total of 51,857 donors were included in this study. The most common Rh antigen found was "e". DCCee was the most prevalent phenotype in our study with the phenotype distribution being significantly different between our study and other studies from different regions of the world. We have determined the prevalence of Rh antigens and Rh phenotypes in the North Indian blood donor population and derived the allele and haplotype frequencies in the same population. The Rh blood group distribution in this population was different from that in other populations.